Please use this identifier to cite or link to this item:
|Title:||Benzimidazole derivatives as potential dual inhibitors for PARP-1 and DHODH||Authors:||Abdullah, I.
Satish Reddy, K.
|Issue Date:||2015||Journal:||Bioorganic and Medicinal Chemistry Volume 23, Issue 15, 23 July 2015, Pages 4669-4680||Abstract:||Poly (ADP-ribose) polymerases (PARPs) play diverse roles in various cellular processes that involve DNA repair and programmed cell death. Amongst these polymerases is PARP-1 which is the key DNA damage-sensing enzyme that acts as an initiator for the DNA repair mechanism. Dihydroorotate dehydrogenase (DHODH) is an enzyme in the pyrimidine biosynthetic pathway which is an important target for anti-hyperproliferative and anti-inflammatory drug design. Since these enzymes share a common role in the DNA replication and repair mechanisms, it may be beneficial to target both PARP-1 and DHODH in attempts to design new anti-cancer agents. Benzimidazole derivatives have shown a wide variety of pharmacological activities including PARP and DHODH inhibition. We hereby report the design, synthesis and bioactivities of a series of benzimidazole derivatives as inhibitors of both the PARP-1 and DHODH enzymes. © 2015 Elsevier Ltd. All rights reserved.||DOI:||10.1016/j.bmc.2015.05.051|
|Appears in Collections:||COE Scholarly Publication|
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.